Natalizumab in Crohn's disease: past and future areas of applicability

por Armuzzi, Alessandro, Felice, Carla
Publicado 2013

Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?

por Armuzzi, Alessandro, Pugliese, Daniela
Publicado 2022

Update on the management of inflammatory bowel disease: specific role of adalimumab

por Guidi, Luisa, Pugliese, Daniela, Armuzzi, Alessandro
Publicado 2011

Frontiers in Drug Research and Development for Inflammatory Bowel Disease

por Currò, Diego, Pugliese, Daniela, Armuzzi, Alessandro
Publicado 2017

Mucosal healing in ulcerative colitis: surveillance or colectomy?

por Andrisani, Gianluca, Papa, Alfredo, Guidi, Luisa, Armuzzi, Alessandro
Publicado 2013

Novel Topics in Inflammatory Bowel Disease

por Sakuraba, Atsushi, Armuzzi, Alessandro, Keyashian, Kian, Naganuma, Makoto
Publicado 2016

Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies

por Armuzzi, Alessandro, Avedano, Luisa, Greveson, Kay, Kang, Taegyun
Publicado 2019

Diet and Nutrients in Gastrointestinal Chronic Diseases

por Corsello, Antonio, Pugliese, Daniela, Gasbarrini, Antonio, Armuzzi, Alessandro
Publicado 2020

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

por Armuzzi, Alessandro, Pugliese, Daniela, Nardone, Olga Maria, Guidi, Luisa
Publicado 2013

Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer

por Privitera, Giuseppe, Rana, Nitish, Scaldaferri, Franco, Armuzzi, Alessandro, Pizarro, Theresa T.
Publicado 2022

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies

por Pugliese, Daniela, Onali, Sara, Privitera, Giuseppe, Armuzzi, Alessandro, Papi, Claudio
Publicado 2022

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

por Felice, Carla, Dal Buono, Arianna, Gabbiadini, Roberto, Rattazzi, Marcello, Armuzzi, Alessandro
Publicado 2023

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

por Pugliese, Daniela, Felice, Carla, Landi, Rosario, Papa, Alfredo, Guidi, Luisa, Armuzzi, Alessandro
Publicado 2016

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”

por Pugliese, Daniela, Papi, Claudio, Privitera, Giuseppe, Aratari, Annalisa, Festa, Stefano, Armuzzi, Alessandro
Publicado 2020

The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI Survey

por Ruggeri, Matteo, Drago, Carlo, Cadeddu, Chiara, Armuzzi, Alessandro, Leone, Salvo, Marchetti, Marco
Publicado 2020

Psychological reaction to Covid-19 of Italian patients with IBD

por Savarese, Mariarosaria, Castellini, Greta, Leone, Salvatore, Previtali, Enrica, Armuzzi, Alessandro, Graffigna, Guendalina
Publicado 2021

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases

por Privitera, Giuseppe, Pugliese, Daniela, Rapaccini, Gian Ludovico, Gasbarrini, Antonio, Armuzzi, Alessandro, Guidi, Luisa
Publicado 2021

Ileal Pouch–Anal Anastomosis and Pouchitis: The Role of the Microbiota in the Pathogenesis and Therapy

por Gabbiadini, Roberto, Dal Buono, Arianna, Correale, Carmen, Spinelli, Antonino, Repici, Alessandro, Armuzzi, Alessandro, Roda, Giulia
Publicado 2022

A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy

por Pugliese, Daniela, Privitera, Giuseppe, Larosa, Luigi, Calvez, Valentin, Broglia, Diana, de Matthaeis, Nicoletta, Armuzzi, Alessandro
Publicado 2022

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

por Corominas, Héctor, Young, David, Cummings, J. R. Fraser, Bouhnik, Yoram, Armuzzi, Alessandro, Thaci, Diamant, Kim, Jihyun
Publicado 2023